Skip to main content

Advertisement

SpringerLink
Log in

Hypogammaglobulinemia in infants receiving chronic peritoneal dialysis

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Peritonitis is a severe complication of chronic peritoneal dialysis (CPD) in infants. Few studies have been conducted to evaluate the relationship between hypogammaglobulinemia and peritonitis risk, and the potential benefit of intravenous immunoglobulins (IVIG) therapy in infants receiving CPD.

Methods

Patients aged 0–12 months at initiation of CPD between 1985 and 2012 were eligible for inclusion in this retrospective study. Data collected from the start of CPD up to 2 years post-dialysis initiation included patient demographics, dialysis characteristics, serum immunoglobulin (IgG) levels, IVIG administration history, infectious complications and outcomes. Cox regression analysis and linear mixed model analysis were used for statistical analysis.

Results

Twenty-six consecutive patients were included in the study. Annualized peritonitis rates for infants aged 0–30 days (≤1-month age group; n = 16; 320.3 patient-months) and 31–365 days (>1–12-month age group; n = 10; 163.3 patient-months) at dialysis initiation were 0.27 (1 episode per 45.8 patient-months) and 0.15 (one episode per 81.7 patient-months), respectively. Seventy-six percent of the serum IgG levels were >1 standard deviation below the age-appropriate mean levels, and these did not differ in those who developed peritonitis versus those who did not (p = 0.39). Serum IgG levels were significantly lower in patients on CPD with oligoanuria than in non-oliguric patients (p = 0.04) and in patients on CPD for >90 days as compared to those who had received CPD for <90 days (p = 0.018). IVIG therapy was provided to 20 patients with hypogammaglobulinemia; this high prevalence of IVIG usage precluded any drawing of conclusion on the potential role of IVIG in the prevention of peritonitis.

Conclusions

Hypogammaglobulinemia is a frequent complication of CPD during infancy. In our experience, it was not associated with an increased risk for peritonitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Zurowska AM, Fischbach M, Watson AR, Edefonti A, Stefanidis CJ, European Paediatric Dialysis Working Group (2013) Clinical practice recommendations for the care of infants with stage 5 chronic kidney disease (CKD5). Pediatr Nephrol 28:1739–1748

    Article  PubMed  Google Scholar 

  2. Warady BA, Bakkaloglu S, Newland J, Cantwell M, Verrina E, Neu A, Chadha V, Yap HK, Schaefer F (2012) Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int 32:S32–S86

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Warady BA, Schaefer F, Holloway M, Alexander S, Kandert M, Piraino B, Salusky I, Tranaeus A, Divino J, Honda M, Mujais S, Verrina E, International Society for Peritoneal Dialysis (ISPD) Advisory Committee on Peritonitis Management in Pediatric Patients (2000) Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int 20:610–624

    CAS  PubMed  Google Scholar 

  4. Ledermann SE, Scanes ME, Fernando ON, Duffy PG, Madden SJ, Trompeter RS (2000) Long-term outcome of peritoneal dialysis in infants. J Pediatr 136:24–29

    Article  CAS  PubMed  Google Scholar 

  5. Vidal E, Edefonti A, Murer L, Gianoglio B, Maringhini S, Pecoraro C, Sorino P, Leozappa G, Lavoratti G, Ratsch IM, Chimenz R, Verrina E, Italian Registry of Paediatric Chronic Dialysis (2012) Peritoneal dialysis in infants: the experience of the Italian Registry of Paediatric Chronic Dialysis. Nephrol Dial Transplant 27:388–395

    Article  PubMed  Google Scholar 

  6. Verrina E, Zacchello G, Perfumo F, Edefonti A, Sorino P, Bassi S, Andreetta B, Cattarelli D, Capasso G, Consalvo G, Lavoratti G, Longo L, Rinaldi S, Gusmano R (1995) Clinical experience in the treatment of infants with chronic peritoneal dialysis. Adv Perit Dial 11:281–284

    CAS  PubMed  Google Scholar 

  7. Van Stralen KJ, Borzych-Dużalka D, Hataya H, Kennedy SE, Jager KJ, Verrina E, Inward C, Rönnholm K, Vondrak K, Warady BA, Zurowska AM, Schaefer F, Cochat P, ESPN/ERA-EDTA registry; IPPN registry; ANZDATA registry; Japanese RRT registry (2014) Outcomes of children starting renal replacement therapy in the neonatal period. Kidney Int 86:168–174

    Article  PubMed  Google Scholar 

  8. Carey WA, Talley LI, Sehring SA, Jaskula JM, Mathias RS (2007) Outcomes of dialysis initiated during the neonatal period for treatment of end-stage renal disease: a North American Pediatric Renal Trials and Collaborative Studies special analysis. Pediatrics 119:e468–e473

    Article  PubMed  Google Scholar 

  9. Neu AM, Warady BA, Lederman HM, Furth SL, Fivush BA (1998) Hypogammaglobulinemia in infants and young children maintained on peritoneal dialysis. Perit Dial Int 18:440–443

    CAS  PubMed  Google Scholar 

  10. Katz A, Kashtan CE, Greenberg LJ, Shapiro RS, Nevins TE, Kim Y (1990) Hypogammaglobulinemia in uremic infants receiving peritoneal dialysis. J Pediatr 117:258–261

    Article  CAS  PubMed  Google Scholar 

  11. Bouts AH, Davin JC, Krediet RT, van der Weel MB, Schröder CH, Monnens L, Nauta J, Out TA (2000) Immunoglobulins in chronic renal failure of childhood: effects of dialysis modalities. Kidney Int 58:629–637

    Article  CAS  PubMed  Google Scholar 

  12. Jolliff CR, Cost KM, Stivrins PC, Grossman PP, Nolte CR, Franco SM, Fijan KJ, Fletcher LL, Shriner HC (1982) Reference intervals for serum IgG, IgA, IgM, C3, and C4 as determined by rate nephelometry. Clin Chem 28:126–128

    CAS  PubMed  Google Scholar 

  13. Lee KO, Park SJ, Kim JH, Lee JS, Kim PK, Il Shin J (2013) Outcomes of peritonitis in children on peritoneal dialysis: a 25-year experience at severance hospital. Yonsei Med J 54:983–989

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lopez-Gonzalez D, Garduno J, Reyes-Lopez A, Partida-Gaytan A, Medeiros M (2015) Risk factors associated with nosocomial peritonitis in children on peritoneal dialysis. Rev Invest Clin 67:170–176

    PubMed  Google Scholar 

  15. Akman S, Guven AG, Ince S, Yegin O (1998) Effect of intraperitoneal immunoglobulin infusion on neutrophil function in CAPD children with and without peritonitis. Adv Perit Dial 14:239–242

    CAS  PubMed  Google Scholar 

  16. Lamperi S, Carozzi S (1989) Peritonitis prevention in CAPD by intraperitoneal IgG. Contrib Nephrol 70:325–329

    Article  CAS  PubMed  Google Scholar 

  17. Carozzi S, Nasini MG, Kunkl A, Cantarella S, Lamperi S (1988) Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy. ASAIO Trans 34:635–639

    CAS  PubMed  Google Scholar 

  18. Koleba T, Ensom MH (2006) Pharmacokinetics of intravenous immunoglobulin: a systematic review. Pharmacotherapy 26:813–827

    Article  CAS  PubMed  Google Scholar 

  19. Van der Meer JW, Van Beem RT, Robak T, Deptala A, Strengers PF (2011) Efficacy and safety of a nano filtered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpura. Vox Sang 101:138–146

    Article  PubMed  Google Scholar 

  20. Wasserman RL, Church JA, Peter HH, Sleasman JW, Melamed I, Stein MR, Bichler J (2009) Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency. Eur J Pharm Sci 37:272–278

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Children’s Mercy Hospital, University of Missouri–Kansas City School of Medicine, 2401 Gillham Road, Kansas City, MO, 64108, USA

    Shwetal Lalan & Bradley A. Warady

  2. Health Services and Outcomes Research, Children’s Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA

    Hongying Dai

Authors
  1. Shwetal Lalan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongying Dai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bradley A. Warady
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bradley A. Warady.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest to report.

Grants and financial support

None to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lalan, S., Dai, H. & Warady, B.A. Hypogammaglobulinemia in infants receiving chronic peritoneal dialysis. Pediatr Nephrol 32, 503–509 (2017). https://doi.org/10.1007/s00467-016-3487-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-016-3487-1

Keywords

Search

Navigation